A revolutionary retinal implant called PRIMA is restoring central vision in patients with geographic atrophy (GA), an advanced macular degeneration affecting about 1 million Americans. Unlike treatments that only slow disease progression, this wireless neurostimulation device captures real-world images, projects them onto a subretinal chip, and stimulates surviving retinal cells to simulate natural vision.
This innovation may represent a major shift in treating vision loss. Chuck Dinerstein discusses this breakthrough on Episode 144 of the Science Dispatch podcast:
“For decades, treatments for macular degeneration have focused on slowing, not restoring vision loss. A new retinal implant is flipping that script, turning patients with geographic atrophy into human–machine hybrids who can see again. It’s not sci-fi; it’s a glimpse at how neuro-engineering might redefine what it means to be blind — and human.”
Listen to Science Dispatch on iTunes, Spotify, Stitcher, and Google Podcasts, or add the RSS feed to any podcast app. Subscribe to the Dispatch newsletter for these stories delivered to your inbox.
Cameron English is a writer, editor, and co-host of the Science Facts and Fallacies Podcast. Before joining ACSH, he was managing editor at the Genetic Literacy Project.
Summary: The PRIMA retinal implant offers new hope by restoring vision in patients with advanced macular degeneration, signaling a potential paradigm shift in treating blindness.